Your browser doesn't support javascript.
loading
Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies.
Duchartre, Yann; Bachl, Stefanie; Kim, Hye Na; Gang, Eun Ji; Lee, Solah; Liu, Hsiao-Chuan; Shung, Kirk; Xu, Ruth; Kruse, Aaron; Tachas, George; Bonig, Halvard; Kim, Yong-Mi.
Affiliation
  • Duchartre Y; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Bachl S; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Kim HN; Institute for Transfusion Medicine and Immunohematology, Goethe University, and German Red Cross Blood Service Baden-Württemberg-Hessen, Frankfurt, Germany.
  • Gang EJ; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Lee S; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Liu HC; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Shung K; Department of Biomedical Engineering, University of Southern California, Los Angeles, United States of America.
  • Xu R; Department of Biomedical Engineering, University of Southern California, Los Angeles, United States of America.
  • Kruse A; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Tachas G; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, United States of America.
  • Bonig H; Department of Pathology, University of Southern California, Los Angeles, United States of America.
  • Kim YM; Antisense Therapeutics Limited, Toorak, Victoria, Australia.
PLoS One ; 12(11): e0187684, 2017.
Article in En | MEDLINE | ID: mdl-29117236

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Oligonucleotides, Antisense / Integrin alpha4 / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Animals / Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Oligonucleotides, Antisense / Integrin alpha4 / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Animals / Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States